{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:23:46Z","timestamp":1783164226393,"version":"3.54.6"},"reference-count":45,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Head &amp; Neck"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>De\u2010escalation strategies for human papillomavirus (HPV)\u2010positive oropharyngeal squamous cell carcinoma (OPSCC) aim to reduce late morbidity while preserving cure rates, but evidence syntheses provide inconsistent conclusions and may be affected by overlap of primary studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed an umbrella review of systematic reviews (SRs) and meta\u2010analyses (MAs) evaluating de\u2010escalation approaches versus standard\u2010of\u2010care therapy in HPV\u2010positive (or p16\u2010positive) OPSCC. MEDLINE (PubMed), Embase, and the Cochrane Database of SRs were searched from inception to December 1, 2025. Two reviewers independently screened records and extracted data. Overlap among included SR\/MAs was quantified using the corrected covered area (CCA); when overlap was substantial, an index review was prioritized based on methodological quality, recency, and completeness of outcomes. Review\u2010level quality and risk of bias were assessed using AMSTAR\u20102 and ROBIS. Strength of evidence was graded with a restricted Ioannidis\u2010style framework (\n                      <jats:italic>p<\/jats:italic>\n                      \u2010value\u2009+\u2009sample\u2010size thresholds). Outcomes included overall survival (OS), progression\u2010free survival (PFS), locoregional control (LRC), distant control, and acute\/late toxicity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Evidence clustered into four domains. (1) Definitive systemic substitution: an RCT\u2010only index MA (five trials;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091560) showed that replacing cisplatin with cetuximab during definitive radiotherapy was associated with inferior OS (HR: 2.83; 95% CI: 1.22\u20136.57) and inferior LRC (HR: 2.78; 95% CI: 1.77\u20134.39), without a statistically significant reduction in late grade \u2265\u20093 toxicity (RR: 0.63; 95% CI: 0.36\u20131.10). The two RCT\u2010only syntheses were fully overlapping (CCA, 100%). (2) Broad de\u2010intensification: across 55 studies (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200938\u2009929), de\u2010intensified strategies were associated with worse OS (HR: 1.33; 95% CI: 1.17\u20131.52), PFS (HR: 2.11; 95% CI: 1.65\u20132.69), LRC (HR: 2.51; 95% CI: 1.75\u20133.59), and distant control (HR: 1.90; 95% CI: 1.25\u20132.90). (3) Post\u2010transoral surgery adjuvant de\u2010intensification: at the time of the Cochrane review (2018), no completed eligible RCTs were identified; updated trial\u2010level data are now available (ADEPT closed early; ECOG\u2010E3311 long\u2010term follow\u2010up published in 2025; PATHOS phase III enrollment completing in 2025). (4) Reduced\u2010dose radiotherapy: evidence remains limited to a registered protocol.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In cisplatin\u2010eligible HPV\u2010positive OPSCC, cetuximab substitution compromises oncologic outcomes without reliable severe late\u2010toxicity reduction; other de\u2010escalation approaches should remain trial\u2010based until robust patient\u2010reported and functional data demonstrate a meaningful net benefit.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hed.70340","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:41:15Z","timestamp":1780454475000},"page":"2281-2289","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["De\u2010Escalation Treatment Strategies in\n                    <scp>HPV<\/scp>\n                    \u2010Positive Oropharyngeal Squamous Cell Carcinoma: An Umbrella Review of Systematic Reviews and Meta\u2010Analyses"],"prefix":"10.1002","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9639-4486","authenticated-orcid":false,"given":"Fausto","family":"Petrelli","sequence":"first","affiliation":[{"name":"Oncology Unit, ASST Bergamo Ovest  Treviglio Bergamo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Trevisan","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, ASST Bergamo Ovest  Treviglio Bergamo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostina","family":"De Stefani","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, ASST Bergamo Ovest  Treviglio Bergamo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Bruschieri","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, ASST Bergamo Ovest  Treviglio Bergamo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Riboldi","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, ASST Bergamo Ovest  Treviglio Bergamo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Nardone","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology Unit, ASST Bergamo Ovest  Treviglio Bergamo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Spada","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology Unit, ASST Bergamo Ovest  Treviglio Bergamo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gasparini","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology Unit, ASST Bergamo Ovest  Treviglio Bergamo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bramati","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology Unit, ASST Bergamo Ovest  Treviglio Bergamo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Ghilardi","sequence":"additional","affiliation":[{"name":"Oncology Unit, ASST Bergamo Ovest  Treviglio Bergamo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bossi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences Humanitas University  Milan Italy"},{"name":"IRCCS Humanitas Research Hospital  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.4596"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.6995"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912217"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.1937"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32752-1"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32779-X"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.8841"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.6647"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.08.033"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70017-6"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01752"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1598-x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30246-2"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2015.03.001"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70346-1"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/jebm.70092"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.06.005"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.081086"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2022.03.009"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17391"},{"key":"e_1_2_6_23_1","article-title":"De\u2010Intensified Adjuvant (Chemo)radiotherapy Versus Standard Adjuvant Chemoradiotherapy Post Transoral Minimally Invasive Surgery for Resectable HPV\u2010Positive OPSCC","volume":"12","author":"Howard J.","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.07.001"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-019-05387-8"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.27019"},{"key":"e_1_2_6_27_1","unstructured":"\u201cAdjuvant De\u2010Escalation Extracapsular Spread P16+ Transoral (ADEPT) Trial \u201dClinicalTrials.gov NCT01687413 accessed December 2025 https:\/\/clinicaltrials.gov\/study\/NCT01687413."},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01752"},{"key":"e_1_2_6_29_1","unstructured":"\u201cPost\u2010Operative Adjuvant Treatment for HPV\u2010Positive Tumours (PATHOS) \u201dClinicalTrials.gov NCT02215265 \/ ISRCTN21785478 accessed December 2025 https:\/\/clinicaltrials.gov\/study\/NCT02215265."},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-21-00159"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70311-0"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.9457"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.0748"},{"issue":"1","key":"e_1_2_6_34_1","first-page":"E658","article-title":"Salvage Surgery for Locally Recurrent Oropharyngeal Cancer","volume":"38","author":"Patel S. N.","year":"2016","journal-title":"Head & Neck"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2017.08.008"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2015.1314"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2017.02.002"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5633"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.104460"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00560-4"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO\u201024\u201002550"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98811"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.6587"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2706-2"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30410-3"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23157"}],"container-title":["Head &amp; Neck"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hed.70340","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hed.70340","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hed.70340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:14:34Z","timestamp":1783163674000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hed.70340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1002\/hed.70340"],"URL":"https:\/\/doi.org\/10.1002\/hed.70340","archive":["Portico"],"relation":{},"ISSN":["1043-3074","1097-0347"],"issn-type":[{"value":"1043-3074","type":"print"},{"value":"1097-0347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"2025-12-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}